Smartlabel, Samrt Pen, Cartridges and Consumables STILL aren't available now in 2018.
Medical Device Approval is not a product, and there is no proof an application was submitted for Canadian Medial Device approval.
Partnerships is not a product, and have minimal impact on financials. (licensing rev fell by $135k from 2016-2017).
Clinical Trails are not a product, but a costs.
So that leaves, CannaDx, 360 (w/ database backend). So currently MYDX is in the same revenue path as 2017.